Cited by 866Liver physiology and pathologyWound Healing and TreatmentsLiver Disease Diagnosis and Treatment

The DOI matches its Crossref record; 126 of the 128 references it cites were found in a registry or an index.

Models of liver fibrosis: exploring the dynamic nature of inflammation and repair in a solid organ

Open access

Iredale, John P.·2007·Journal of Clinical Investigation

Open this paper in CoChat — free account Open PDF

Abstract

Models of liver fibrosis, which include cell culture models, explanted and biopsied human material, and experimental animal models, have demonstrated that liver fibrosis is a highly dynamic example of solid organ wound healing. Recent work in human and animal models has shown that liver fibrosis is potentially reversible and, in specific circumstances, demonstrates resolution with a restoration of near normal architecture. This Review highlights the manner in which studies of models of liver fibrosis have contributed to the paradigm of dynamic wound healing in this solid organ.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1172/jci30542

Cites

126 of 126 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Molecular Mechanisms of Stress-Responsive Changes in Collagen and Elastin Networks in Skin
Aziz, J., Shezali, H., Radzi, Z., Yahya, N. A., Abu Kassim, N. H., Czernuszka, J., & Rahman, M. T. (2016) · Skin Pharmacology and Physiology · doi:10.1159/000447017 · Cited by 7,323
Liver fibrosis
Bataller, R., & Brenner, D. A. (2005) · Journal of Clinical Investigation · doi:10.1172/jci24282 · Cited by 4,958
The Versatile Role of microRNA-30a in Human Cancer
Wang, C., Yang, X., Chen, Y., & Chen, L. (2017) · Cellular Physiology and Biochemistry · doi:10.1159/000471111 · Cited by 3,414
Macrophages that have ingested apoptotic cells in vitro inhibit proinflammatory cytokine production through autocrine/paracrine mechanisms involving TGF-beta, PGE2, and PAF.
Fadok, V. A., Bratton, D. L., Konowal, A., Freed, P. W., Westcott, J. Y., & Henson, P. M. (1998) · Journal of Clinical Investigation · doi:10.1172/jci1112 · Cited by 3,166
Nonalcoholic Steatohepatitis
Ludwig, J., Viggiano, T. R., McGill, D. B., & Ott, B. J. (1980) · Mayo Clinic Proceedings · doi:10.1016/s0025-6196(24)00530-5 · Cited by 2,903
Epithelial-mesenchymal transition and its implications for fibrosis
Kalluri, R., & Neilson, E. G. (2003) · Journal of Clinical Investigation · doi:10.1172/jci20530 · Cited by 2,715
Molecular Regulation of Hepatic Fibrosis, an Integrated Cellular Response to Tissue Injury
Friedman, S. L. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.4.2247 · Cited by 2,067
Liver fibrosis – from bench to bedside
Friedman, S. L. (2003) · Journal of Hepatology · doi:10.1016/s0168-8278(02)00429-4 · Cited by 1,780
Selective depletion of macrophages reveals distinct, opposing roles during liver injury and repair
Duffield, J. S., Forbes, S. J., Constandinou, C. M., Clay, S., Partolina, M., Vuthoori, S., Wu, S., Lang, R., & Iredale, J. P. (2005) · Journal of Clinical Investigation · doi:10.1172/jci200522675 · Cited by 1,649
Self-citation
Fusion of bone-marrow-derived cells with Purkinje neurons, cardiomyocytes and hepatocytes
Álvarez‐Dolado, M., Pardal, R., García‐Verdugo, J. M., Fike, J. R., Lee, H. O., Pfeffer, K., Lois, C., Morrison, S. J., & Álvarez-Buylla, A. (2003) · Nature · doi:10.1038/nature02069 · Cited by 1,617

Flagged first, then by citations

Show all 128 references

2 of the 128 references couldn’t be matched to a known paper.

Research works printed but not linked: 9

10.1172/JCI200524282 · DOI · Paper page
Otto, 1980, Adv. Exp. Med. Biol., 132, 509
Constandinou, 2005, Methods Mol. Med., 117, 237
Montfort, 1978, Am. J. Pathol., 92, 411
Jeong, 2002, Anticancer Res., 22, 869
Okazaki, 1998, Lab. Invest., 78, 1431
10.1172/JCI200320530 · DOI
10.1053/gast.1996.v110.pm8608892 · DOI · Paper page
10.1074/jbc.275.4.2247 · DOI

Sorted by citations

Items 301–400 of 865

Pluripotent Stem Cell–Derived Hepatocytes: Potential and Challenges in Pharmacology
Szkolnicka, D., Zhou, W., Lucendo‐Villarin, B., & Hay, D. C. (2013) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-011112-140306 · Cited by 51
Acute decompensation boosts hepatic collagen type III deposition and deteriorates experimental and human cirrhosis
Praktiknjo, M., Lehmann, J., Nielsen, M. J., Schierwagen, R., Uschner, F. E., Meyer, C., Thomas, D., Strassburg, C. P., Bendtsen, F., Møller, S., et al. (2018) · Hepatology Communications · doi:10.1002/hep4.1135 · Cited by 49
Interleukin-17A plays a pivotal role in cholestatic liver fibrosis in mice
Hara, M., Kono, H., Furuya, S., Hirayama, K., Tsuchiya, M., & Fujii, H. (2013) · Journal of Surgical Research · doi:10.1016/j.jss.2013.03.025 · Cited by 50
The genus Crocus L.: A review of ethnobotanical uses, phytochemistry and pharmacology
Mohtashami, L., Amiri, M. S., Ramezani, M., Emami, S. A., & Simal‐Gándara, J. (2021) · Industrial Crops and Products · doi:10.1016/j.indcrop.2021.113923 · Cited by 50
Molecular MRI quantification of extracellular aldehyde pairs for early detection of liver fibrogenesis and response to treatment
Ning, Y., Zhou, I. Y., Roberts, J. D., Rotile, N. J., Akam, E., Barrett, S. C., Sojoodi, M., Barr, M. N., Punshon, T., Pantazopoulos, P., et al. (2022) · Science Translational Medicine · doi:10.1126/scitranslmed.abq6297 · Cited by 47
Liver cirrhosis: An overview of experimental models in rodents
Faccioli, L. A. P., Dias, M. L., Paranhos, B. A., & dos Santos Goldenberg, R. C. (2022) · Life Sciences · doi:10.1016/j.lfs.2022.120615 · Cited by 47
Transplantation of bone marrow–derived mesenchymal stem cells after regional hepatic irradiation ameliorates thioacetamide-induced liver fibrosis in rats
Shao, C., Chen, S., Dong, T., Chai, H., Yu, Y. Y., Deng, L., Wang, Y., & Cheng, F. (2013) · Journal of Surgical Research · doi:10.1016/j.jss.2013.08.016 · Cited by 47
COMMD1-Deficient Dogs Accumulate Copper in Hepatocytes and Provide a Good Model for Chronic Hepatitis and Fibrosis
Favier, R. P., Spee, B., Schotanus, B. A., van den Ingh, T. S. G. A. M., Fieten, H., Brinkhof, B., Viebahn, C. S., Penning, L. C., & Rothuizen, J. J. (2012) · PLoS ONE · doi:10.1371/journal.pone.0042158 · Cited by 46
Fibrogenic cell reversion underlies fibrosis regression in liver
Friedman, S. L. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1206645109 · Cited by 45
Antifibrotic effects of gallic acid on hepatic stellate cells: In vitro and in vivo mechanistic study
El-Lakkany, N. M., El-Maadawy, W. H., el-Din, S. H. S., Saleh, S., Safar, M. M., Ezzat, S. M., Mohamed, S. H., Botros, S. S., Demerdash, Z. A., & Hammam, O. A. (2018) · Journal of Traditional and Complementary Medicine · doi:10.1016/j.jtcme.2018.01.010 · Cited by 47
Methylation of Septin9 mediated by DNMT3a enhances hepatic stellate cells activation and liver fibrogenesis
Wu, Y., Bu, F., Yu, H., Li, W., Huang, C., Meng, X., Zhang, L., Ma, T., & Li, J. (2016) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2016.12.002 · Cited by 49
The common dietary flavonoid myricetin attenuates liver fibrosis in carbon tetrachloride treated mice
Geng, Y., Sun, Q., Li, W., Lu, Z., Xu, H., Shi, J., & Xu, Z. (2016) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201600392 · Cited by 46
IL-33-ST2 Axis in Liver Disease: Progression and Challenge
Sun, Z., Chang, B., Gao, M., Zhang, J., & Zou, Z. (2017) · Mediators of Inflammation · doi:10.1155/2017/5314213 · Cited by 47
Advances in the research of nanodrug delivery system for targeted treatment of liver fibrosis
Peng, W. J., Cheng, S., Bao, Z., Wang, Y., Zhou, W. J., Wang, J., Yang, Q., Chen, C., & Wang, W. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.111342 · Cited by 47
Therapeutic Effects of Berberine on Liver Fibrosis are associated With Lipid Metabolism and Intestinal Flora
Liu, X., Wang, L., Tan, S., Chen, Z., Wu, B., & Wu, X. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.814871 · Cited by 45
Matrix Metalloproteinases and Their Inhibitors
Campana, L., & Iredale, J. P. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-800134-9.00007-5 · Cited by 45
Self-citation
Epithelial–Mesenchymal Transition in Kidney Tubular Epithelial Cells Induced by Globotriaosylsphingosine and Globotriaosylceramide
Jeon, Y. J., Jung, N., Park, J., Park, H., & Jung, S. (2015) · PLoS ONE · doi:10.1371/journal.pone.0136442 · Cited by 45
Danshensu, a novel indoleamine 2,3-dioxygenase1 inhibitor, exerts anti-hepatic fibrosis effects via inhibition of JAK2-STAT3 signaling
Cao, G., Zhu, R., Jiang, T., Tang, D., Kwan, H. Y., & Su, T. (2019) · Phytomedicine · doi:10.1016/j.phymed.2019.153055 · Cited by 44
Mesenchymal Stem Cells Influence Activation of Hepatic Stellate Cells, and Constitute a Promising Therapy for Liver Fibrosis
Lee, C., Kim, M.-J., Han, J., Yoon, M. H., & Jung, Y. (2021) · Biomedicines · doi:10.3390/biomedicines9111598 · Cited by 48
Differential Roles of Angiogenesis in the Induction of Fibrogenesis and the Resolution of Fibrosis in Liver
Park, S., Kim, J., Kim, J., Lim, C. W., & Kim, B. (2015) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.b15-00325 · Cited by 43
Conditional loss of heparin-binding EGF-like growth factor results in enhanced liver fibrosis after bile duct ligation in mice
Takemura, T., Yoshida, Y., Kiso, S., Kizu, T., Furuta, K., Ezaki, H., Hamano, M., Egawa, M., Chatani, N., Kamada, Y., et al. (2013) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2013.05.097 · Cited by 43
Prevalence and Importance of Comorbidities in Patients With Heart Failure
Triposkiadis, F. K., & Skoularigis, J. S. (2012) · Current Heart Failure Reports · doi:10.1007/s11897-012-0110-z · Cited by 43
Long-Term Exposure to Low-Dose Di-(2-ethylhexyl) Phthalate Impairs Cholesterol Metabolism in Hepatic Stellate Cells and Exacerbates Liver Fibrosis
Lee, C.-Y., Suk, F., Twu, Y., & Liao, Y. (2020) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph17113802 · Cited by 43
Increased Liver Uptake and Reduced Hepatic Stellate Cell Activation with a Cell-Specific Conjugate of the Rho-kinase Inhibitor Y27632
van Beuge, M. M., Prakash, J., Lacombe, M., Post, E., Reker‐Smit, C., Beljaars, L., & Poelstra, K. (2011) · Pharmaceutical Research · doi:10.1007/s11095-011-0430-9 · Cited by 43
Natural Progression of Non-Alcoholic Steatohepatitis to Hepatocellular Carcinoma
Ramai, D., Tai, W., Rivera, M. L., Facciorusso, A., Tartaglia, N., Pacilli, M., Ambrosi, A., Cotsoglou, C., & Sacco, R. (2021) · Biomedicines · doi:10.3390/biomedicines9020184 · Cited by 44
[18F]-Alfatide PET imaging of integrin αvβ3 for the non-invasive quantification of liver fibrosis
Shao, T., Chen, Z., Belov, V., Wang, X., Rwema, S., Kumar, V., Fu, H., Deng, X., Rong, J., Yu, Q., et al. (2020) · Journal of Hepatology · doi:10.1016/j.jhep.2020.02.018 · Cited by 41
Mistletoe alkaloid fractions alleviates carbon tetrachloride-induced liver fibrosis through inhibition of hepatic stellate cell activation via TGF-β/Smad interference
Jiang, Y., Wang, C., Li, Y., Wang, X., An, J.-D., Wang, Y., & Wang, X. (2014) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2014.10.028 · Cited by 41
Targeting stromal cells for the treatment of platelet-derived growth factor C-induced hepatocellular carcinogenesis
Campbell, J. S., Johnson, M. M., Bauer, R. L., Hudkins, K. L., Gilbertson, D. G., Riehle, K. J., Yeh, M. M., Alpers, C. E., & Fausto, N. (2007) · Differentiation · doi:10.1111/j.1432-0436.2007.00235.x · Cited by 41
Is Western Diet-Induced Nonalcoholic Steatohepatitis in Ldlr-/- Mice Reversible?
Lytle, K. A., & Jump, D. Β. (2016) · PLoS ONE · doi:10.1371/journal.pone.0146942 · Cited by 42
Preventive effects of total saponins of Panax japonicus on fatty liver fibrosis in mice
Yuan, D., Xiang, T., Huo, Y., Liu, C., Wang, T., Zhou, Z., Dun, Y., Zhao, H., & Zhang, C. (2016) · Archives of Medical Science · doi:10.5114/aoms.2016.63260 · Cited by 41
Quantitative ultrasound and machine learning for assessment of steatohepatitis in a rat model
Tang, A., Destrempes, F., Kazemirad, S., Garcia-Duitama, J., Nguyen, B., & Cloutier, G. (2018) · European Radiology · doi:10.1007/s00330-018-5915-z · Cited by 41
Hepatic Fibrosis and Cirrhosis
Rockey, D. C. (2015) · Wiley eBooks · doi:10.1002/9781118512074.ch105 · Cited by 41
Network pharmacology combines machine learning, molecular simulation dynamics and experimental validation to explore the mechanism of acetylbinankadsurin A in the treatment of liver fibrosis
Peng, W., Yang, Y., Lu, H., Shi, H., Jiang, L., Liao, X., Zhao, H., Wang, W., & Liu, J. (2023) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2023.117682 · Cited by 40
LncRNA HULC affects the differentiation of Treg in HBV-related liver cirrhosis
Zhao, J., Fan, Y., Wang, K., Ni, X., Gu, J., Lu, H., Lu, Y., Lu, L., Dai, X., & Wang, X. (2015) · International Immunopharmacology · doi:10.1016/j.intimp.2015.04.028 · Cited by 40
Increased contractility of hepatic stellate cells in cirrhosis is mediated by enhanced Ca2+-dependent and Ca2+-sensitization pathways
Iizuka, M., Murata, T., Hori, M., & Ozaki, H. (2011) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00350.2010 · Cited by 40
Liver Fibrosis: Understanding the Dynamics of Bidirectional Wound Repair to Inform the Design of Markers and Therapies
Iredale, J. P., Pellicoro, A., & Fallowfield, J. A. (2017) · Digestive Diseases · doi:10.1159/000456581 · Cited by 40
Self-citation
Pirfenidone alleviates concanavalin A-induced liver fibrosis in mice
Salah, M. M., Ashour, A. A., Abdelghany, T. M., Abdel‐Aziz, A. H., & Salama, S. A. (2019) · Life Sciences · doi:10.1016/j.lfs.2019.116982 · Cited by 40
Biopsy-Controlled Liver Fibrosis Staging Using the Enhanced Liver Fibrosis (ELF) Score Compared to Transient Elastography
Wahl, K., Rosenberg, W. M., Vaske, B., Manns, M. P., Schulze‐Osthoff, K., Bahr, M. J., & Bantel, H. (2012) · PLoS ONE · doi:10.1371/journal.pone.0051906 · Cited by 39
Anti‐fibrotic activity and enhanced interleukin‐6 production by hepatic stellate cells in response to imatinib mesylate
Kim, Y., Fiel, M. I., Albanis, E., Chou, H., Zhang, W., Khitrov, G., & Friedman, S. L. (2012) · Liver International · doi:10.1111/j.1478-3231.2012.02806.x · Cited by 39
Hepatic Fibrosis in a Long-term Murine Model of Sepsis
Gonnert, F. A., Kunisch, E., Gajda, M. R., Lambeck, S., Weber, M., Claus, R. A., Bauer, M. W., & Kinne, R. W. (2012) · Shock · doi:10.1097/shk.0b013e31824a670b · Cited by 39
Elastin-based molecular MRI of liver fibrosis
Ehling, J., Bartneck, M., Fech, V., Butzbach, B., Cesati, R. R. I., Botnar, R. M., Lammers, T., & Tacke, F. (2013) · Hepatology · doi:10.1002/hep.26326 · Cited by 39
Mechanisms and therapeutic targets of mitochondria in the progression of metabolic dysfunction-associated steatotic liver disease
Mu, C., Wang, S., Wang, Z., Tan, J., Yin, H.-Z., Wang, Y., Dai, Z., Ding, D., & Yang, F. (2024) · Annals of Hepatology · doi:10.1016/j.aohep.2024.101774 · Cited by 40
Reversal of hepatic fibrosis: pathophysiological basis of antifibrotic therapies
Ismail, M. H., & Pinzani, M. (2011) · Hepatic Medicine Evidence and Research · doi:10.2147/hmer.s9051 · Cited by 38
Mechanistic aspects of antifibrotic effects of honokiol in Con A-induced liver fibrosis in rats: Emphasis on TGF-β/SMAD/MAPK signaling pathways
Elfeky, M. G., Mantawy, E. M., Gad, A. M., Fawzy, H. M., & El‐Demerdash, E. (2019) · Life Sciences · doi:10.1016/j.lfs.2019.117096 · Cited by 38
Circulating fibronectin isoforms predict the degree of fibrosis in chronic hepatitis C
Hackl, N., Bersch, C., Feick, P., Antoni, C., Franke, A., Singer, M. V., & Nakchbandi, I. A. (2009) · Scandinavian Journal of Gastroenterology · doi:10.3109/00365520903490606 · Cited by 38
Characterisation of the hepatic progenitor cell compartment in normal liver and in hepatitis: An immunohistochemical comparison between dog and man
IJzer, J., Schotanus, B. A., Borght, S. V., Roskams, T., Kisjes, R., Penning, L. C., Rothuizen, J. J., & van den Ingh, T. S. G. A. M. (2009) · The Veterinary Journal · doi:10.1016/j.tvjl.2009.02.016 · Cited by 38
Interplays of liver fibrosis-associated microRNAs: Molecular mechanisms and implications in diagnosis and therapy
Li, H., Liu, T., Yang, Y., Cho, W. C. S., Flynn, R. J., Harandi, M. F., Song, H., Luo, X., & Zheng, Y. (2022) · Genes & Diseases · doi:10.1016/j.gendis.2022.08.013 · Cited by 39
Tianhuang formula ameliorates liver fibrosis by inhibiting CCL2-CCR2 axis and MAPK/NF-κB signaling pathway
Lan, T., Chen, B., Hu, X., Cao, J., Chen, S., Ding, X., Li, S., Fu, Y., Liu, H., Luo, D., et al. (2023) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2023.117516 · Cited by 37
Transformation of macrophages into myofibroblasts in fibrosis-related diseases: emerging biological concepts and potential mechanism
Li, X., Liu, Y., Tang, Y., & Xia, Z. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1474688 · Cited by 46
Aqueous Date Flesh or Pits Extract Attenuates Liver Fibrosis via Suppression of Hepatic Stellate Cell Activation and Reduction of Inflammatory Cytokines, Transforming Growth Factor-β1 and Angiogenic Markers in Carbon Tetrachloride-Intoxicated Rats
Al-Rasheed, N. M., Attia, H., Mohamad, R. A., Al‐Rasheed, N. M., Alamin, M. A., & Alonazi, A. S. (2015) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2015/247357 · Cited by 37
The Role of Ceramide in the Pathogenesis of Alcoholic Liver Disease
Liu, Y., Jin, G., & Zhou, J. (2015) · Alcohol and Alcoholism · doi:10.1093/alcalc/agv119 · Cited by 36
Emerging Role of HMGB1 in the Pathogenesis of Schistosomiasis Liver Fibrosis
Vicentino, A. R. R., Carneiro, V. C., Allonso, D., Guilherme, R. F., Benjamim, C. F., dos Santos, H. A. M., Xavier, F. R., Pyrrho, A. D. S., Gomes, J. D. A. S., Fonseca, M. D. C., et al. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01979 · Cited by 37
Beneficial Effects ofOcimum gratissimumAqueous Extract on Rats with CCl4-Induced Acute Liver Injury
Chiu, C., Huang, C., Chen, T., Kao, S., Liu, J.-Y., Wang, Y.-W., Tzang, B., & Hsu, T. (2012) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2012/736752 · Cited by 37
Bone marrow-derived fibrocytes contribute to liver fibrosis
Xu, J., & Kisseleva, T. (2015) · Experimental Biology and Medicine · doi:10.1177/1535370215584933 · Cited by 37
DNA methylation in fibrosis
Dowson, C., & O’Reilly, S. (2016) · European Journal of Cell Biology · doi:10.1016/j.ejcb.2016.06.003 · Cited by 37
Neutralization of Interleukin‐17 Attenuates Cholestatic Liver Fibrosis in Mice
Zhang, S., Huang, D., Weng, J., Huang, Y., Liu, S., Zhang, Q., Li, N., Wen, M., Zhu, G., Lin, F., et al. (2016) · Scandinavian Journal of Immunology · doi:10.1111/sji.12395 · Cited by 36
Murine Models of Acute Alcoholic Hepatitis and Their Relevance to Human Disease
Wilkin, R. J. W., Lalor, P. F., Parker, R., & Newsome, P. N. (2016) · The American Journal of Pathology · doi:10.1016/j.ajpath.2015.12.003 · Cited by 36
Upregulation of cannabinoid receptor-1 and fibrotic activation of mouse hepatic stellate cells during Schistosoma J. infection: Role of NADPH oxidase
Wang, M., Abais, J. M., Meng, N., Zhang, Y., Ritter, J. K., Li, P. L., & Tang, W.-X. (2014) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2014.03.015 · Cited by 36
RNA Interference against Discoidin Domain Receptor 2 Ameliorates Alcoholic Liver Disease in Rats
Luo, Z. L., Liu, H., Sun, X., Guo, R., Cui, R., Ma, X., & Yan, M. (2013) · PLoS ONE · doi:10.1371/journal.pone.0055860 · Cited by 35
Role of Hepatic Deposited Immunoglobulin G in the Pathogenesis of Liver Damage in Systemic Lupus Erythematosus
Fang, X., Zaman, M. H., Guo, X., Ding, H., Xie, C., Zhang, X., & Deng, G. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01457 · Cited by 36
Genetic Determinants in Hepatic Fibrosis: From Experimental Models to Fibrogenic Gene Signatures in Humans
Weber, S. N., Gressner, O. A., Hall, R. A., Grünhage, F., & Lammert, F. (2008) · Clinics in Liver Disease · doi:10.1016/j.cld.2008.07.012 · Cited by 36
Liver immunity, autoimmunity, and inborn errors of immunity
Parlar, Y. E., Ayar, Ş. N., Cağdaş, D. N., & Balaban, Y. H. (2023) · World Journal of Hepatology · doi:10.4254/wjh.v15.i1.52 · Cited by 36
Cu,Zn-SOD deficiency induces the accumulation of hepatic collagen
Sakiyama, H., Fujiwara, N., 米岡由佳, Yoshihara, D., Eguchi, H., & Suzuki, K. (2016) · Free Radical Research · doi:10.3109/10715762.2016.1164856 · Cited by 35
Sevelamer Improves Steatohepatitis, Inhibits Liver and Intestinal Farnesoid X Receptor (FXR), and Reverses Innate Immune Dysregulation in a Mouse Model of Non-alcoholic Fatty Liver Disease
McGettigan, B. M., McMahan, R. H., Luo, Y., Wang, X. X., Orlicky, D. J., Porsche, C. E., Levi, M., & Rosen, H. R. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.731042 · Cited by 36
Induction of liver fibrosis in a murine hepatoma model by thioacetamide is associated with enhanced tumor growth and suppressed antitumor immunity
Yang, M.-C., Chang, C., & Lei, H.-Y. (2010) · Laboratory Investigation · doi:10.1038/labinvest.2010.139 · Cited by 35
Paeoniflorin regulates macrophage activation in dimethylnitrosamine-induced liver fibrosis in rats
Chen, X., Liu, C., Lu, Y., Yang, Z., Lv, Z., Xu, Q., Pan, Q., & Lu, L. (2012) · BMC Complementary and Alternative Medicine · doi:10.1186/1472-6882-12-254 · Cited by 35
Synergistic antifibrotic efficacy of statin and protein kinase C inhibitor in hepatic fibrosis
Yang, J. I., Yoon, J., Bang, Y., Lee, S.-H., Lee, S., Byun, H. J., Myung, S. J., Kim, W. K., & Lee, H.-S. (2009) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00299.2009 · Cited by 35
Fibrosis in the Liver
Lee, Y., & Friedman, S. L. (2010) · Progress in molecular biology and translational science · doi:10.1016/b978-0-12-385233-5.00006-4 · Cited by 37
Models and Mechanisms of Fibrosis Resolution
Snowdon, V., & Fallowfield, J. A. (2011) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.2010.01400.x · Cited by 35
GGPPS deficiency aggravates CCl 4 ‐induced liver injury by inducing hepatocyte apoptosis
Chen, W., Lai, S., Yu, D., Liu, J., Jiang, S., Zhao, D., Ding, Y.-T., Li, C., & Xue, B. (2015) · FEBS Letters · doi:10.1016/j.febslet.2015.03.015 · Cited by 34
Antifibrotic effects of CGX, a traditional herbal formula, and its mechanisms in rats
Wang, J., Shin, J., Son, J.-Y., Cho, J.-H., & Son, C. (2009) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2009.10.001 · Cited by 34
Mechanism of autoimmune hepatic fibrogenesis induced by an adenovirus encoding the human liver autoantigen cytochrome P450 2D6
Hintermann, E., Ehser, J., Bayer, M., Pfeilschifter, J. M., & Christen, U. (2013) · Journal of Autoimmunity · doi:10.1016/j.jaut.2013.05.001 · Cited by 34
Pathogenesis and treatment of hepatic fibrosis: is cirrhosis reversible?
Fallowfield, J. A., & Hayes, P. C. (2011) · Clinical Medicine · doi:10.7861/clinmedicine.11-2-179 · Cited by 35
Pro- and Anti-fibrogenic Functions of Gram-Negative Bacterial Lipopolysaccharide in the Liver
Gandhi, C. R. (2020) · Frontiers in Medicine · doi:10.3389/fmed.2020.00130 · Cited by 34
Ischemic preconditioning and intermittent clamping confer protection against ischemic injury in the cirrhotic mouse liver
Jang, J. H., Kang, K.-J., Kang, Y., Lee, I., Graf, R., & Clavien, P. (2008) · Liver Transplantation · doi:10.1002/lt.21467 · Cited by 34
Swertiamarin Attenuates Experimental Rat Hepatic Fibrosis by Suppressing Angiotensin II–Angiotensin Type 1 Receptor–Extracellular Signal-Regulated Kinase Signaling
Li, S., Wang, Q., Tao, Y., & Liu, C. (2016) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.116.234179 · Cited by 34
Assessment of liver fibrosis using T1 mapping on Gd-EOB-DTPA-enhanced magnetic resonance
Sheng, R. F., Wang, H. Q., Yang, L., Jin, K. P., Xie, Y. H., Fu, C. X., & Zeng, M. S. (2017) · Digestive and Liver Disease · doi:10.1016/j.dld.2017.02.006 · Cited by 34
Liver fibrosis: pathological features, clinical treatment and application of therapeutic nanoagents
Chen, L., Guo, W., Mao, C., Shen, J., & Wan, M. (2024) · Journal of Materials Chemistry B · doi:10.1039/d3tb02790b · Cited by 33
TGF-β inhibitors: the future for prevention and treatment of liver fibrosis?
Wang, W., Gao, Y., Chen, Y., Cheng, M., Sang, Y., Wei, L., Dai, R., Wang, Y., & Zhang, L. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1583616 · Cited by 37
TGF-β1 accelerates the hepatitis B virus X-induced malignant transformation of hepatic progenitor cells by upregulating miR-199a-3p
Dong, K., Chen, Y., Yang, G., Liao, Z., Zhang, H., Liang, H., Chen, X., & Dong, H. (2019) · Oncogene · doi:10.1038/s41388-019-1107-9 · Cited by 33
Losartan Enhances the Success of Myoblast Transplantation
Fakhfakh, R., Lamarre, Y., Skuk, D., & Tremblay, J. P. (2011) · Cell Transplantation · doi:10.3727/096368911x576045 · Cited by 33
Platelets prime hematopoietic–vascular niche to drive angiocrine-mediated liver regeneration
Shido, K., Chavez, D., Cao, Z., KO, J. L., Rafii, S., & Ding, B. (2017) · Signal Transduction and Targeted Therapy · doi:10.1038/sigtrans.2016.44 · Cited by 33
Quantification of Vascular Remodeling and Sinusoidal Capillarization to Assess Liver Fibrosis with Photoacoustic Imaging
Li, W., Lv, J., Li, H., Song, L., Zhang, R., Zhao, X., Xuan, F., Sun, T., Long, K., Zhao, Y., et al. (2025) · Radiology · doi:10.1148/radiol.241275 · Cited by 32
Hypotheses on the Role of Transforming Growth Factor-β in the Onset and Progression of Hepatocellular Carcinoma
Dooley, S., Weng, H., & Mertens, P. R. (2009) · Digestive Diseases · doi:10.1159/000218340 · Cited by 32
Tissue Inhibitor of Matrix-Metalloprotease–1 Predicts Risk of Hepatic Fibrosis in Human Schistosoma japonicum Infection
Fabre, V., Wu, H.-W., Pond‐Tor, S., Coutinho, H. M., Acosta, L. P., Jiz, M., Olveda, R. M., Cheng, L., White, E. S., Jarilla, B. R., et al. (2011) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiq099 · Cited by 32
Involvement of fibroblast-specific protein 1 (S100A4) and matrix metalloproteinase-13 (MMP-13) in CCl4-induced reversible liver fibrosis
Louka, M. L., & Ramzy, M. M. (2015) · Gene · doi:10.1016/j.gene.2015.12.042 · Cited by 32
Promising hepatoprotective effects of lycopene in different liver diseases
Ibrahim, I. M., Althagafy, H. S., Abd‐alhameed, E. K., Al-Thubiani, W. S., & Hassanein, E. H. M. (2022) · Life Sciences · doi:10.1016/j.lfs.2022.121131 · Cited by 33
Garlic extract attenuating rat liver fibrosis by inhibiting TGF-β1
D’Argenio, G., Mazzone, G., Ribecco, M. T. S., Lembo, V., Vitaglione, P., Guarino, M., Morisco, F., Napolitano, M., Fogliano, V., & Caporaso, N. (2012) · Clinical Nutrition · doi:10.1016/j.clnu.2012.07.001 · Cited by 32
RETRACTED: 14‐Deoxyandrographolide desensitizes hepatocytes to tumour necrosis factor‐alpha‐induced apoptosis through calcium‐dependent tumour necrosis factor receptor superfamily member 1A release via the NO/cGMP pathway
Roy, D. N., Mandal, S., Sen, G., Mukhopadhyay, S., & Biswas, T. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.00836.x · Cited by 31
Retracted
Hepatic regeneration and the epithelial to mesenchymal transition
Xue, Z. (2013) · World Journal of Gastroenterology · doi:10.3748/wjg.v19.i9.1380 · Cited by 32
eIF2α phosphorylation is required to prevent hepatocyte death and liver fibrosis in mice challenged with a high fructose diet
Choi, W.-G., Han, J., Kim, J.-H., Kim, M. J., Park, J.-W., Song, B., Cha, H.-J., Choi, H., Chung, H., Lee, I. K., et al. (2017) · Nutrition & Metabolism · doi:10.1186/s12986-017-0202-6 · Cited by 30
PBI-4050 Reduces Stellate Cell Activation and Liver Fibrosis through Modulation of Intracellular ATP Levels and the Liver Kinase B1/AMP-Activated Protein Kinase/Mammalian Target of Rapamycin Pathway
Grouix, B., Sarra‐Bournet, F., Leduc, M., Simard, J.-C., Hince, K., Geerts, L., Blais, A., Gervais, L., Laverdure, A., Felton, A., et al. (2018) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.118.250068 · Cited by 31
Dose-Dependent Antifibrotic Effect of Chrysin on Regression of Liver Fibrosis: The Role in Extracellular Matrix Remodeling
Baltă, C., Ciceu, A., Herman, H., Roșu, M., Boldura, O. M., & Hermenean, A. O. (2018) · Dose-Response · doi:10.1177/1559325818789835 · Cited by 32
Hydroxysafflor yellow A induces apoptosis in activated hepatic stellate cells through ERK1/2 pathway in vitro
Li, C., Chun-zhuang, Y., Li, X.-M., Zhao, X., Zou, Y. S., Fan, L., Li, Z., Liu, J., & Niu, Y. (2012) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2012.03.003 · Cited by 31
Diethylcarbamazine Reduces Chronic Inflammation and Fibrosis in Carbon Tetrachloride- (CCl 4 -) Induced Liver Injury in Mice
Rocha, S. W. S., de França, M. E. R., Rodrigues, G. B., Barbosa, K. P. S., Nunes, A. K. S., Pastor, A. F., de Oliveira, A. G. V., de Oliveira, W. H., Luna, R. L., & Peixoto, C. A. (2014) · Mediators of Inflammation · doi:10.1155/2014/696383 · Cited by 31
Proteasomal Degradation of Enhancer of Zeste Homologue 2 in Cholangiocytes Promotes Biliary Fibrosis
Jalan‐Sakrikar, N., de Assuncao, T. M., Shi, G., Aseem, S. O., Chi, C., Shah, V. H., & Huebert, R. C. (2019) · Hepatology · doi:10.1002/hep.30706 · Cited by 31
Liver fibrosis: from mechanisms to treatment
Friedman, S. L. (2007) · Gastroentérologie Clinique et Biologique · doi:10.1016/s0399-8320(07)73970-2 · Cited by 31
Immunohistochemical characterization of glial fibrillary acidic protein (GFAP)-expressing cells in a rat liver cirrhosis model induced by repeated injections of thioacetamide (TAA)
Tennakoon, A. H., Izawa, T., Wijesundera, K. K., Murakami, H., Katou-Ichikawa, C., Tanaka, M., Golbar, H. M., Kuwamura, M., & Yamate, J. (2014) · Experimental and Toxicologic Pathology · doi:10.1016/j.etp.2014.09.008 · Cited by 29
The differential effects of low birth weight and Western diet consumption upon early life hepatic fibrosis development in guinea pig
Sarr, O., Blake, A., Thompson, J. A., Zhao, L., Rabicki, K., Walsh, J. C., Welch, I. D., & Regnault, T. R. H. (2015) · The Journal of Physiology · doi:10.1113/jp271777 · Cited by 30
Lipopolysaccharide Reverses Hepatic Stellate Cell Activation Through Modulation of cMyb, Small Mothers Against Decapentaplegic, and CCAAT/Enhancer‐Binding Protein C/EBP Transcription Factors
Sharma, A., Verma, A. K., Kofron, M. J., Kudira, R., Miethke, A. G., Wu, T., Wang, J., & Gandhi, C. R. (2020) · Hepatology · doi:10.1002/hep.31188 · Cited by 29

Authors: Iredale, J. P.
Affiliations: Centre for Inflammation Research (GB)
Corresponding author: Iredale, John P.
ORCID: Iredale, John P.
Venue: Journal of Clinical Investigation
Publisher: American Society for Clinical Investigation
Published: 2007-03-01
Volume: 117
Issue: 3
Pages: 539-548
ISSN: 0021-9738 (ISSN-L)
DOI: 10.1172/jci30542
PMC: PMC1804370
OpenAlex: W2120335459
Cited by: 866
References: 128
Citations by year: 2026: 19 · 2025: 40 · 2024: 45 · 2023: 39 · 2022: 32 · 2021: 39 · 2020: 34 · 2019: 36 · 2018: 39 · 2017: 36 · 2016: 51 · 2015: 63 · 2014: 61 · 2013: 57 · 2012: 55
FWCI: 7.58
Type: journal article
Language: en
Open access: bronze
doi.org
Locations: Journal of Clinical Investigation (publishedVersion)
PubMed Central (publishedVersion)
PubMed (publishedVersion)
Edinburgh Research Explorer (University of Edinburgh) (submittedVersion, other-oa)
Funders: Wellcome Trust
Children's Liver Disease Foundation
Medical Research Council
Topics: Health Sciences › Medicine › Hepatology › Liver physiology and pathology
Health Sciences › Medicine › Surgery › Wound Healing and Treatments
Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
Keywords: liver fibrosis, wound healing, inflammation, tissue repair, animal models, cell culture model, liver regeneration
MeSH terms: Animals, Disease Models, Animal, Extracellular Matrix, Fibroblasts, Humans, Inflammation, Liver Cirrhosis, Liver Cirrhosis, Experimental, Liver Regeneration, Models, Biological, Wound Healing

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Models of liver fibrosis: exploring the dynamic nature of inflammation and repair in a solid organ

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks